90 related articles for article (PubMed ID: 21838419)
1. Relationship between amyloid fibril formation and overproduction of basement membrane components in familial amyloidotic polyneuropathy (FAP).
Misumi Y; Ando Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Uchino M
Amyloid; 2011 Jun; 18 Suppl 1():22-3. PubMed ID: 21838419
[No Abstract] [Full Text] [Related]
2. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy.
Misumi Y; Ando Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Uchino M
J Pathol; 2009 Dec; 219(4):481-90. PubMed ID: 19790249
[TBL] [Abstract][Full Text] [Related]
3. Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on Familial Amyloidotic Polyneuropathy.
Misumi Y; Ueda M; Obayashi K; Jono H; Yamashita T; Ando Y
Amyloid; 2012 Jun; 19 Suppl 1():8-10. PubMed ID: 22524183
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
Hou X; Aguilar MI; Small DH
FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
[TBL] [Abstract][Full Text] [Related]
5. Antibody therapy for familial amyloidotic polyneuropathy.
Su Y; Jono H; Torikai M; Hosoi A; Soejima K; Guo J; Tasaki M; Misumi Y; Ueda M; Shinriki S; Shono M; Obayashi K; Nakashima T; Sugawara K; Ando Y
Amyloid; 2012 Jun; 19 Suppl 1():45-6. PubMed ID: 22506915
[TBL] [Abstract][Full Text] [Related]
6. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
7. Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis.
Sun X; Ueda M; Yamashita T; Nakamura M; Bergström J; Zeledon Ramirez ME; Okajima M; Misumi S; Shoji S; Motomiya Y; Ando Y
Amyloid; 2006 Mar; 13(1):20-3. PubMed ID: 16690496
[TBL] [Abstract][Full Text] [Related]
8. Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
Misumi Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Ohshima T; Ando Y; Uchino M
Hum Pathol; 2012 Jan; 43(1):96-104. PubMed ID: 21777941
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation.
Matsunaga N; Anan I; Forsgren S; Nagai R; Rosenberg P; Horiuchi S; Ando Y; Suhr OB
Acta Neuropathol; 2002 Nov; 104(5):441-7. PubMed ID: 12410391
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy.
Mazzeo A; Aguennouz M; Messina C; Vita G
Arch Neurol; 2004 Jul; 61(7):1097-102. PubMed ID: 15262741
[TBL] [Abstract][Full Text] [Related]
11. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
[TBL] [Abstract][Full Text] [Related]
12. Only amyloidogenic intermediates of transthyretin induce apoptosis.
Andersson K; Olofsson A; Nielsen EH; Svehag SE; Lundgren E
Biochem Biophys Res Commun; 2002 Jun; 294(2):309-14. PubMed ID: 12051711
[TBL] [Abstract][Full Text] [Related]
13. Liver mitochondrial function in familial amyloidotic polyneuropathy.
Castro e Silva O; Sankarankutty AK; Souza ME; Picinato MA; Fina CF; Jordani MC; Mente ED; Cagnolatti D; Teixeira AC; Souza FF; Martinelli AL; Rondon LZ
Transplant Proc; 2008 Apr; 40(3):771-3. PubMed ID: 18455012
[TBL] [Abstract][Full Text] [Related]
14. Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients.
Susuki S; Ando Y; Sato T; Nishiyama M; Miyata M; Suico MA; Shuto T; Kai H
Amyloid; 2008 Jun; 15(2):108-16. PubMed ID: 18484337
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end product is implicated in amyloid-related kidney complications.
Matsunaga N; Anan I; Rosenberg P; Nagai R; Lundström O; Horiuchi S; Ando Y; Suhr OB
Scand J Clin Lab Invest; 2005; 65(4):263-71. PubMed ID: 16076681
[TBL] [Abstract][Full Text] [Related]
16. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
Kawaji T; Ando Y; Nakamura M; Yamashita T; Wakita M; Ando E; Hirata A; Tanihara H
Ophthalmology; 2005 Dec; 112(12):2212. PubMed ID: 16225929
[TBL] [Abstract][Full Text] [Related]
17. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
18. Focus on autonomic dysfunction in familial amyloidotic polyneuropathy (FAP).
Obayashi K; Ando Y
Amyloid; 2012 Jun; 19 Suppl 1():28-9. PubMed ID: 22620964
[TBL] [Abstract][Full Text] [Related]
19. Recurrent syncope as persistently isolated feature of transthyretin amyloidotic polyneuropathy.
Vita G; Mazzeo A; Di Leo R; Ferlini A
Neuromuscul Disord; 2005 Mar; 15(3):259-61. PubMed ID: 15725588
[TBL] [Abstract][Full Text] [Related]
20. Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy.
Ferreira N; Saraiva MJ; Almeida MR
Amyloid; 2012 Jun; 19 Suppl 1():39-42. PubMed ID: 22620965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
